🇺🇸 L-methylfolate in United States
390 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 390
Most-reported reactions
- Nausea — 55 reports (14.1%)
- Headache — 45 reports (11.54%)
- Anxiety — 44 reports (11.28%)
- Fatigue — 43 reports (11.03%)
- Depression — 38 reports (9.74%)
- Drug Ineffective — 37 reports (9.49%)
- Dizziness — 34 reports (8.72%)
- Pain — 32 reports (8.21%)
- Diarrhoea — 31 reports (7.95%)
- Vomiting — 31 reports (7.95%)
Frequently asked questions
Is L-methylfolate approved in United States?
L-methylfolate does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for L-methylfolate in United States?
Queen's University is the originator. The local marketing authorisation holder may differ — check the official source linked above.